Singapore markets close in 7 hours 10 minutes
Straits Times Index
3,302.20 +9.27 (+0.28%) Nikkei
38,236.07 -38.03 (-0.10%) Hang Seng
18,496.87 +20.95 (+0.11%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
64,173.91 +1,050.63 (+1.66%) CMC Crypto 200
1,336.59 +59.61 (+4.67%)
ABT Nov 2024 90.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:18AM EDT. Market open.
| Previous close | 1.5700 |
| Open | 1.5700 |
| Bid | 1.3700 |
| Ask | 1.5100 |
| Strike | 90.00 |
| Expiry date | 2024-11-15 |
| Day's range | 1.5700 - 1.5700 |
| Contract range | N/A |
| Volume | |
| Open interest | 124 |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.